Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis

Maureen J. Aarts, Birgit E. Vriens, Maaike de Boer, Frank P. Peters, Caroline M. Mandigers, M. Wouter Dercksen, Jacqueline M. Stouthard, Jolien Tol, Laurence J. van Warmerdam, Agnes J. van de Wouw, Esther M. Jacobs, Carin C. D. van der Rij, Tineke J. Smilde, Annette W. van der Velden, Nelly Peer, Vivianne C. G. Tjan-Heijnen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)323-328
Number of pages6
JournalOncology
Volume93
Issue number5
DOIs
Publication statusPublished - 2017

Keywords

  • Breast cancer
  • Granulocyte colony-stimulating factor prophylaxis
  • Neutrophil
  • Chemotherapy
  • INDUCED FEBRILE NEUTROPENIA
  • CELL LUNG-CANCER
  • PHASE-III
  • PEGFILGRASTIM
  • RISK
  • PHARMACOKINETICS
  • MULTICENTER
  • PREVENTION
  • 1ST

Cite this